Sources

8 Total Sources

Life Biosciences Doses 1st Patient With ER-100 for Glaucoma as Aging-Reversal Gene Therapy Enters Human Testing

Life Biosciences Doses First Patient with ER-100 Gene Therapy to Reverse Cellular Aging for Glaucoma

Business Insider38d ago

Life Biosciences Injects First Human with Cellular Reprogramming Drug to Reverse Aging

lifespan.io38d ago

First Human Cellular Reprogramming Trial Cleared by the FDA

ScienceAlert37d ago

Life Biosciences Doses First Patient with ER-100 for Age-Related Vision Loss

Life Biosciences Doses First Human with ER-100 for Age-Related Sight Loss

Harvard Medical School38d ago

Loss of Epigenetic Information Can Drive Aging, Restoration Can Reverse It | Harvard Medical School

Facebook38d ago

In a proof-of-concept experiment, researchers at Michigan Medicine and Michigan Engineering designed several human cell types that were genetically modified with protein nanoparticles. With the nanoparticles, the research team aims to develop

BioSpace38d ago

BioSpace: Biotech, Pharmaceutical and Clinical Research News